Canadian drug maker Valeant Pharmaceuticals International, Inc. said it has appointed Sam Eldessouky as senior vice president and corporate controller, with effect from May 31, 2016. The appointment is the latest in a raft of management changes at the company, which has been criticized for its accounting and business practices.